TROG's mission is "To conduct world-class research in radiation medicine that leads the global effort to better control and cure cancer. We are helping improve outcomes for people affected by cancer, through the conduct of high quality, practice changing clinical trials."
We stive to improve access and participation in clinical trials because we value equity.
However, there are clear and longstanding disparities in cancer outcomes and access to clinical trials in Australia.
The landscape of radiation medicine is changing. RANZCR data shows that more and more patients from regional and rural areas are accessing their treatment at centres closer to home. The scope of trials in radiation medicine has become more technologically driven and perhaps metrocentric.
Enabling access to clinical trial for regional patients in Australia is good for patients and essential for TROG.